More tools:Markets·Screener·Research·Chat

Xtant Medical Holdings, Inc. (XTNT) Financial Statements

Xtant Medical Holdings, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001T6FJR5
XASE · usd
0.37▼ 0.01 (-2.66%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.38
Day's Range0.37 – 0.41
52-Week Range0.27 – 0.95
Volume520.6K
Avg Volume3.2M
Share Statistics
Shares Outstanding
Employees151
ExchangeXASE
Listed2007-01-31
Share count as of August 7, 2026
Loading Income Statement…
Key questions about Xtant Medical Holdings, Inc. (XTNT)
What is Xtant Medical Holdings, Inc.'s Market Cap?
Xtant Medical Holdings, Inc.'s Market Cap is $51.9M, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s Enterprise Value?
Xtant Medical Holdings, Inc.'s Enterprise Value is $53.1M, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s Price / Sales?
Xtant Medical Holdings, Inc.'s Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s EV / Revenue?
Xtant Medical Holdings, Inc.'s EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s EV / EBITDA?
Xtant Medical Holdings, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s Revenue (TTM)?
Xtant Medical Holdings, Inc.'s Revenue (TTM) is $109.5M, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s Net Income (TTM)?
Xtant Medical Holdings, Inc.'s Net Income (TTM) is -$11.1M, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s EBITDA?
Xtant Medical Holdings, Inc.'s EBITDA is -$6.5M, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s Diluted EPS (TTM)?
Xtant Medical Holdings, Inc.'s Diluted EPS (TTM) is -0.08, based on as-reported figures from SEC (XBRL) filings.
What is Xtant Medical Holdings, Inc.'s EBITDA Margin?
Xtant Medical Holdings, Inc.'s EBITDA Margin is -5.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Revenue
YoY growth-35.0%-36.5%+2.7%+19.0%
Cost of Revenue
Gross Profit
% of revenue57.9%57.3%54.9%66.1%
Operating Expenses
Selling, General and Administrative Expense
Research and Development Expense
Write-off of distribution agreement deposit———
Total Operating Expenses
% of revenue97.7%71.3%57.8%58.5%
(Loss) Income from Operations
% of revenue-39.8%-14.0%-2.9%7.6%
Other Expense
Interest expense
Interest and Dividend Income (Non-Bank)——
Non-Operating Income (Expense)
Total Other Expense
Net (Loss) Income from Operations Before Provision for Income Taxes
Provision for Income Taxes Current and Deferred
Net (Loss) Income
% of revenue-40.9%-14.8%0.2%3.9%
Earnings Per Share
Earnings Per Share (Basic)
Earnings Per Share (Diluted)